Neutralizing antibody durability and SARS-CoV-2 infection in older adults six months after XBB-containing vaccine booster
{{output}}
The persistence of XBB-containing vaccine-induced immunity against evolving SARS-CoV-2 variants remains uncertain, particularly in older adults, who are at increased risk of severe outcomes and may experience more rapid immune decline. We previously reported n... ...
